. "Appendix P: Prospects for Immunizing Against Streptococcus group B." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
Pass, M.A., B.M.Gray, and H.C.Dillon. 1982. Puerperal and perinatal infections with group B streptococci. Am. J. Obstet. Gynecol. 143(2):147–152.
Polk, B.F. 1983. Personal communication, Johns Hopkins University, Baltimore, Md.
Pyati, S.P., R.S.Pildes, N.M.Jacobs, R.S.Ramamurthy, T.F.Yeh, D.S. Raval, L.D.Lilien, P.Amma, and W.I.Metzger. 1983. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N. Engl. J. Med. 308(23):1383–1389.
Santos, J.I., A.O.Shigeoka, N.S.Rote, and H.R.Hill. 1981. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. J. Pediatr. 99(6):873–879.
Vogel, L.C., R.R.Kretschmer, D.M.Padnos, P.D.Kelly, and S.P.Gotoff. 1980. Protective value of gamma globulin preparations against group B streptococcal infections in chick embryos and mice. Pediatr. Res. 14(1):788–792.
Wald, E., I.Bergman, D.Chiponis, and K.Kubek. 1984. Long-term outcome of group B streptococcal meningitis, abstracted. Pediatr. Research 18:116A.
Wilkinson, H.W. 1978. Analysis of group B streptococcal types associated with disease in human infants and adults. J. Clin. Microbiol. 7(1):176–179.
